Glenmark’s Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19
NE HEALTH BUREAU AHMEDABAFD, NOV 25 The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, ...